AMIVANTAMAB and HYALURONIDASE-lpuj (HUMAN RECOMBINANT)

FDA Drug Profile — Rybrevant Faspro

AMIVANTAMAB and HYALURONIDASE-lpuj (HUMAN RECOMBINANT) is listed in the FDA National Drug Code directory with 12 NDC codes, marketed under brand name including Rybrevant Faspro. Available dosage form: injection.

Drug details

Generic Name
AMIVANTAMAB and HYALURONIDASE-lpuj (HUMAN RECOMBINANT)
Brand Names
Rybrevant Faspro
Application Number
BLA761433
Sponsor
Janssen Biotech, Inc.
NDC Codes
12
Dosage Forms
INJECTION
Routes
SUBCUTANEOUS
Active Ingredients
AMIVANTAMAB, HYALURONIDASE (HUMAN RECOMBINANT)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.